Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oleg Gluz

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
In Vivo (Athens, Greece)|June 28, 2017
A Head to Head Comparison Between SurgiMend® - Fetal Bovine Acellular Dermal Matrix and Tutomesh® - A Bovine Pericardium Collagen Membrane in Breast Reconstruction in 45 CasesChristian Eichler, Jeria Efremova, Klaus Brunnert, et al.
Anticancer Research|March 9, 2012
Intraoperative ultrasound: improved resection rates in breast-conserving surgeryChristian Eichler, Annette Hübbel, Verena Zarghooni, et al.
Trials|August 21, 2013
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trialDaniel Hofmann, Ulrike Nitz, Oleg Gluz, et al.
Therapeutic Advances in Medical Oncology|March 17, 2025
Efficacy of sacituzumab govitecan versus treatment of physician's choice in previously treated HR+ and HER2- mBC: a meta-analysis of TROPiCS-02 and EVER-132-002 trialsOleg Gluz, Binghe Xu, Rita Nanda, et al.
Geburtshilfe Und Frauenheilkunde|June 21, 2019
Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) - Recommendations for Daily Routine PracticeAndreas Schneeweiss, Carsten Denkert, Peter A Fasching, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
Association of HER2 Overexpression and Prognosis in Small (T1N0) Primary Breast CancersJoachim Rom, Claudia Schumacher, Oleg Gluz, et al.
Geburtshilfe Und Frauenheilkunde|September 4, 2024
Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast CancerEugen Ruckhäberle, Marcus Schmidt, Anja Welt, et al.
Genes, Chromosomes & Cancer|December 7, 2018
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profilingMatthias Christgen, Stephan Bartels, Martin Radner, et al.
Breast Cancer Research and Treatment|July 22, 2015
The prognostic impact of age in different molecular subtypes of breast cancerCornelia Liedtke, Achim Rody, Oleg Gluz, et al.
Plos One|July 29, 2016
Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast CancerEva Lorsy, Aylin Sophie Topuz, Cordelia Geisler, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
In Vivo (Athens, Greece)|June 28, 2017
A Head to Head Comparison Between SurgiMend® - Fetal Bovine Acellular Dermal Matrix and Tutomesh® - A Bovine Pericardium Collagen Membrane in Breast Reconstruction in 45 CasesChristian Eichler, Jeria Efremova, Klaus Brunnert, et al.
Anticancer Research|March 9, 2012
Intraoperative ultrasound: improved resection rates in breast-conserving surgeryChristian Eichler, Annette Hübbel, Verena Zarghooni, et al.
Trials|August 21, 2013
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trialDaniel Hofmann, Ulrike Nitz, Oleg Gluz, et al.
Therapeutic Advances in Medical Oncology|March 17, 2025
Efficacy of sacituzumab govitecan versus treatment of physician's choice in previously treated HR+ and HER2- mBC: a meta-analysis of TROPiCS-02 and EVER-132-002 trialsOleg Gluz, Binghe Xu, Rita Nanda, et al.
Geburtshilfe Und Frauenheilkunde|June 21, 2019
Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) - Recommendations for Daily Routine PracticeAndreas Schneeweiss, Carsten Denkert, Peter A Fasching, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
Association of HER2 Overexpression and Prognosis in Small (T1N0) Primary Breast CancersJoachim Rom, Claudia Schumacher, Oleg Gluz, et al.
Geburtshilfe Und Frauenheilkunde|September 4, 2024
Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast CancerEugen Ruckhäberle, Marcus Schmidt, Anja Welt, et al.
Genes, Chromosomes & Cancer|December 7, 2018
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profilingMatthias Christgen, Stephan Bartels, Martin Radner, et al.
Breast Cancer Research and Treatment|July 22, 2015
The prognostic impact of age in different molecular subtypes of breast cancerCornelia Liedtke, Achim Rody, Oleg Gluz, et al.
Plos One|July 29, 2016
Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast CancerEva Lorsy, Aylin Sophie Topuz, Cordelia Geisler, et al.
Pageof 10